Human 85 kDa LRP Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Human 85 kDa LRP antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityHuman 85 kDa LRP
Clone[5A6]
Host SpeciesMouse
Reactive Specieshuman, mouse, rabbit
IsotypeIgG2b kappa
Formatbiotin conjugate
Size0.1 mg, 1 mg
Concentration4.15 mg/ml
ApplicationsELISA (EIA), Flow Cytometry, Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (IHC) Formalin/Paraffin, Western Blot (WB), Immunoprecipitation (IP)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionBiotin labeled monoclonal antibody to human 85 kDa light chain of LRP. Purified by immobilized Protein A. IgG2b class.
ImmunogenImmunogen: Full length native protein (purified) (Human). Target Information: Recognises the 85kDa cleaved fragment of Low Density LRP (extracellular domain). Target Molecular Weight: 85000
Other Names[prolow-density lipoprotein receptor-related protein 1; Prolow-density lipoprotein receptor-related protein 1; prolow-density lipoprotein receptor-related protein 1; LRP-1; type V tgf-beta receptor; apolipoprotein E receptor; alpha-2-macroglobulin receptor; TbetaR-V/LRP-1/IGFBP-3 receptor; low density lipoprotein receptor-related protein 1; Alpha-2-macroglobulin receptor; A2MR; Apolipoprotein E receptor], [LRP1; LRP1; APR; LRP; A2MR; CD91; APOER; LRP1A; TGFBR5; IGFBP3R; A2MR; APR; LRP-1; A2MR; APOER; LRP-85; LRP-515; LRPICD]
Gene, Accession #[LRP1], Gene ID: 4035, NCBI: NP_002323.2, UniProt: Q07954
Catalog #MBS135017
Price$305, $1855
Order / More InfoHuman 85 kDa LRP Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.